Drug and medical device maker Eli Lilly says its earnings rose 44 percent in the second quarter as sales growth was helped in part by the weaker dollar.

Indianapolis-based Eli Lilly & Co. says it earned $958.8 million, or 88 cents per share, compared with $663.6 million, or 61 cents per share, in the same quarter last year.

Excluding one-time costs for restructuring and an acquisition, the company says it earned 99 cents per share in the latest period.

Lilly says revenue increased 11 percent to $5.15 billion from $4.63 billion.

Analysts polled by Thomson Financial expected earnings of $1 per share on revenue of $5.03 billion.

The company says it now expects lower full-year earnings per share, including one-time items, of $3.79 to $3.94, down from prior estimates of $3.90 to $4.05.